The US Supreme Court will hear arguments in a landmark case over whether state tort claims against Roundup (glyphosate) are preempted by EPA’s federal carcinogen ruling.
Key Takeaways
The core legal question is federal preemption: the EPA has classified glyphosate as non-carcinogenic since 1991, and the Court must decide if that blocks state-level cancer liability suits.
IARC’s 2015 classification of glyphosate as a probable carcinogen contradicts EPA’s stance, creating the regulatory conflict that produced billions in jury verdicts against Bayer/Monsanto.
A ruling for Bayer would effectively shield products from state tort law whenever a federal agency has cleared them – with implications far beyond Roundup.
Glyphosate is the active ingredient in Roundup, the world’s most widely used herbicide; Bayer acquired it through the 2018 Monsanto acquisition.
Hacker News Comment Review
HN consensus is that the science strongly favors glyphosate’s safety: commenters with technical backgrounds call it one of the most benign herbicides available, especially relative to organophosphate alternatives.
The IARC decision is treated skeptically; commenters note it was controversial within global public health circles and that the EPA’s “Group E” classification (affirmative evidence of non-carcinogenicity) predates it by decades.
Practical concern raised: glyphosate may be the only effective control for invasive species like Japanese knotweed – a concrete agricultural and ecological argument for keeping it available.
Notable Comments
@tptacek: detailed breakdown of the federal/state law interface, IARC controversy, and why the legal stakes extend well beyond glyphosate itself.
@chromacity: draws parallels to DDT, microplastics, and aspartame as cases where public-opinion verdicts diverge sharply from scientific evidence.
